| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | ESPN EPS8 WIPF1 MAP1A MYO9B TPRN SYNPO2L SYNPO FMNL2 SPATA31C1 PXK AFAP1 XIRP2 FMN1 MYPN DIAPH1 MYO18B FMNL1 | 8.75e-08 | 479 | 164 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | URI1 ABI1 MAP1A PPRC1 NACA KSR2 MED14 ICE1 BCL11A KAT2A DRAP1 SH2B2 SH2B1 NCOR2 TSC22D1 KMT2D MAMSTR PXN MAP3K10 SMARCC2 IRS2 POLD3 TOX2 UTF1 HR | 9.04e-06 | 1160 | 164 | 25 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | URI1 PPRC1 NACA MED14 BCL11A KAT2A DRAP1 NCOR2 TSC22D1 KMT2D MAMSTR MAP3K10 SMARCC2 TOX2 UTF1 HR | 1.65e-05 | 562 | 164 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin binding | SFPQ URI1 ARX PER1 CHD3 KAT2A KDM6B MBD6 CIC NCOR2 SALL1 PELP1 AUTS2 SMARCC2 MLLT6 NKX6-1 TOX2 HR | 3.85e-05 | 739 | 164 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | molecular adaptor activity | URI1 ABI1 MAP1A PPRC1 NACA KSR2 MED14 ICE1 BCL11A KAT2A DRAP1 HCN2 SH2B2 SH2B1 NCOR2 TSC22D1 KMT2D MAMSTR PXN MAP3K10 SMARCC2 IRS2 POLD3 TOX2 UTF1 HR | 4.42e-05 | 1356 | 164 | 26 | GO:0060090 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | FOXS1 CUX2 DEAF1 ARX CC2D1A BCL11A BCL6B MLXIPL SALL1 YLPM1 NKX6-1 | 7.03e-05 | 320 | 164 | 11 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | FOXS1 CUX2 DEAF1 ARX CC2D1A BCL11A BCL6B MLXIPL SALL1 YLPM1 NKX6-1 | 8.29e-05 | 326 | 164 | 11 | GO:0001217 |
| GeneOntologyMolecularFunction | profilin binding | 1.46e-04 | 13 | 164 | 3 | GO:0005522 | |
| GeneOntologyMolecularFunction | transcription factor binding | PPRC1 NACA MED14 PER1 BCL11A KAT2A DRAP1 FOXA3 NCOR2 MLXIPL SALL1 MAP3K10 FOXH1 TOX2 TRIB1 UTF1 HR | 1.60e-04 | 753 | 164 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.82e-04 | 143 | 164 | 7 | GO:0017124 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ESPN EPS8 ABI1 WIPF1 MAP1A MYO9B TPRN SYNPO2L SYNPO FMNL2 SPATA31C1 PXK AFAP1 XIRP2 FMN1 MYPN DIAPH1 PXN RFLNA MYO18B FMNL1 | 2.70e-04 | 1099 | 164 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | protein domain specific binding | ESPN ABI1 WIPF1 PHRF1 ACVR2A HCN2 FOXA3 SH2B2 SOCS7 HOXA3 AFAP1 FMN1 MYPN PXN TNK2 IRS2 FOXH1 UTF1 | 3.18e-04 | 875 | 164 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase adaptor activity | 4.05e-04 | 18 | 164 | 3 | GO:0005068 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 6.93e-04 | 129 | 164 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.22e-04 | 303 | 164 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.01e-03 | 54 | 164 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | protein kinase activity | SPEG TGFBR3L KSR2 PKDCC ACVR2A LMTK3 PXK MAP3K10 TNK2 TRIB1 MAP4K2 WNK2 SBK3 | 1.39e-03 | 600 | 164 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TENT4A SPEG TGFBR3L KSR2 PKDCC ACVR2A LMTK3 PXK DGKK MAP3K10 TNK2 TNKS POLD3 TRIB1 MAP4K2 WNK2 SBK3 | 1.87e-03 | 938 | 164 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SPEG TGFBR3L KSR2 PKDCC ACVR2A LMTK3 PXK DGKK MAP3K10 TNK2 TRIB1 MAP4K2 WNK2 SBK3 | 2.18e-03 | 709 | 164 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 2.32e-03 | 9 | 164 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 2.48e-03 | 33 | 164 | 3 | GO:0017025 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ESPN EPS8 ABI1 WIPF1 CARMIL3 IQSEC2 SYNPO2L ARHGEF18 SYNPO ARHGEF17 FMNL2 SH2B2 ARHGEF15 CELSR1 XIRP2 FMN1 MYPN PCDH15 DIAPH1 LRP1 KANK4 PXN AUTS2 RFLNA MYO18B FMNL1 AGAP2 | 2.48e-10 | 803 | 165 | 27 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | ESPN EPS8 ABI1 WIPF1 MYO9B CARMIL3 IQSEC2 SYNPO2L ARHGEF18 SYNPO ARHGEF17 FMNL2 SH2B2 ARHGEF15 CELSR1 XIRP2 FMN1 MYPN PCDH15 DIAPH1 LRP1 KANK4 PXN AUTS2 RFLNA MYO18B FMNL1 AGAP2 | 8.64e-10 | 912 | 165 | 28 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament organization | ESPN EPS8 ABI1 WIPF1 CARMIL3 SYNPO2L ARHGEF18 SYNPO ARHGEF15 XIRP2 FMN1 PCDH15 DIAPH1 KANK4 PXN RFLNA | 3.47e-06 | 509 | 165 | 16 | GO:0007015 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CUX2 ABI1 MAP1A RAPH1 TPRN ARX CC2D1A BCL11A DSCAML1 LHX1 MEGF8 GORASP1 MYPN PCDH15 DIAPH1 LRP1 AUTS2 NKX6-1 ROBO3 | 9.00e-06 | 748 | 165 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPS8 CUX2 ABI1 MAP1A RAPH1 MYO9B TPRN ARX ARHGEF18 CC2D1A BCL11A FMNL2 DSCAML1 LHX1 MEGF8 GORASP1 MYPN PCDH15 DIAPH1 LRP1 PXN AUTS2 NKX6-1 ROBO3 FMNL1 | 9.52e-06 | 1194 | 165 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SFPQ DEAF1 ZNF48 PPRC1 NACA ARX MED14 PER1 KAT2A ACVR2A KDM6B FOXA3 MLXIPL TSC22D1 KMT2D SALL1 PELP1 MAMSTR AUTS2 MCRS1 MLLT6 TNKS NKX6-1 FOXH1 TOX2 UTF1 AGAP2 | 1.56e-05 | 1390 | 165 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ESPN EPS8 MAP1A CARMIL3 SYNPO2L ARHGEF18 SYNPO KAT2A ARHGEF15 CELSR1 XIRP2 FMN1 DIAPH1 LRP1 KANK4 PXN | 1.73e-05 | 579 | 165 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ESPN EPS8 SFPQ LRFN1 MAP1A PHF23 CARMIL3 SYNPO2L ARHGEF18 SYNPO KAT2A SH2B1 ARHGEF15 CELSR1 TBC1D4 XIRP2 FMN1 YLPM1 ADAMTS16 DIAPH1 LRP1 KANK4 PXN SMARCC2 MCRS1 TNKS | 2.39e-05 | 1342 | 165 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 2.82e-05 | 195 | 165 | 9 | GO:0061572 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXS1 CUX2 SFPQ URI1 DEAF1 NACA ARX PER1 CC2D1A CHD3 BCL11A KAT2A DRAP1 CIC BCL6B NCOR2 MLXIPL SALL1 YLPM1 SMARCC2 NKX6-1 FOXH1 | 3.57e-05 | 1053 | 165 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXS1 CUX2 SFPQ URI1 DEAF1 NACA ARX PER1 CC2D1A CHD3 BCL11A KAT2A DRAP1 CIC BCL6B LHX1 NCOR2 MLXIPL SALL1 YLPM1 RBM15B MAP3K10 SMARCC2 NKX6-1 FOXH1 HR | 4.83e-05 | 1399 | 165 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXS1 CUX2 SFPQ URI1 DEAF1 NACA ARX PER1 CC2D1A CHD3 BCL11A KAT2A DRAP1 CIC BCL6B LHX1 NCOR2 MLXIPL SALL1 YLPM1 RBM15B MAP3K10 SMARCC2 NKX6-1 FOXH1 HR | 5.70e-05 | 1413 | 165 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | EPS8 CARMIL3 SYNPO2L ARHGEF18 SYNPO ARHGEF15 CELSR1 XIRP2 FMN1 LRP1 KANK4 PXN | 6.40e-05 | 384 | 165 | 12 | GO:0032956 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CUX2 ABI1 MAP1A RAPH1 MYO9B ARX CC2D1A BCL11A DSCAML1 LHX1 MEGF8 GORASP1 MYPN DIAPH1 LRP1 AUTS2 NKX6-1 ROBO3 | 1.03e-04 | 819 | 165 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron recognition | 1.09e-04 | 59 | 165 | 5 | GO:0008038 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CUX2 ABI1 MAP1A RAPH1 MYO9B ARX CC2D1A BCL11A DSCAML1 LHX1 MEGF8 GORASP1 MYPN DIAPH1 LRP1 AUTS2 NKX6-1 ROBO3 | 1.14e-04 | 826 | 165 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 1.55e-04 | 191 | 165 | 8 | GO:0051017 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | EPS8 CARMIL3 SYNPO2L ARHGEF18 SYNPO ARHGEF15 XIRP2 FMN1 KANK4 PXN | 1.57e-04 | 300 | 165 | 10 | GO:0110053 |
| GeneOntologyBiologicalProcess | ureteric bud invasion | 1.90e-04 | 3 | 165 | 2 | GO:0072092 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ESPN EPS8 ABCA2 CUX2 LRFN1 PHF23 CARMIL3 IQSEC2 SYNPO2L ARHGEF18 ADGRL1 CC2D1A SYNPO ICE1 KAT2A ARHGEF15 FMN1 ADAMTS16 LRP1 KANK4 PXN AUTS2 | 2.08e-04 | 1189 | 165 | 22 | GO:0044087 |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 2.13e-04 | 15 | 165 | 3 | GO:0072283 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | EPS8 CARMIL3 SYNPO2L ARHGEF18 SYNPO ARHGEF15 CELSR1 XIRP2 FMN1 LRP1 KANK4 PXN | 2.19e-04 | 438 | 165 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 2.22e-04 | 107 | 165 | 6 | GO:0051492 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ESPN EPS8 ABI1 WIPF1 MAP1A CARMIL3 SYNPO2L RANBP9 ARHGEF18 SYNPO ARHGEF15 XIRP2 FMN1 MYPN PCDH15 DIAPH1 KANK4 PXN RFLNA | 2.43e-04 | 957 | 165 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CUX2 ABI1 MAP1A RAPH1 ARX CC2D1A BCL11A DSCAML1 LHX1 MEGF8 GORASP1 MYPN DIAPH1 LRP1 AUTS2 NKX6-1 ROBO3 | 2.47e-04 | 802 | 165 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 3.76e-04 | 18 | 165 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 3.76e-04 | 18 | 165 | 3 | GO:0072077 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle formation | 3.78e-04 | 4 | 165 | 2 | GO:0072093 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 4.43e-04 | 19 | 165 | 3 | GO:0072087 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 4.50e-04 | 122 | 165 | 6 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 4.70e-04 | 123 | 165 | 6 | GO:0032231 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 5.57e-04 | 127 | 165 | 6 | GO:0043149 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 5.57e-04 | 127 | 165 | 6 | GO:0030038 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | ESPN EPS8 ABCA2 MAP1A PHF23 ARHGEF18 BCL11A KAT2A ARHGEF15 TBC1D4 GORASP1 DIAPH1 LRP1 KANK4 MCRS1 TNKS PRKCSH | 5.78e-04 | 864 | 165 | 17 | GO:0051129 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | DEAF1 CECR2 KAT2A LHX1 CELSR1 SALL1 MEGF8 FMN1 ADAMTS16 PXN FOXH1 | 5.96e-04 | 421 | 165 | 11 | GO:0060562 |
| GeneOntologyBiologicalProcess | axonogenesis | MAP1A RAPH1 ARX BCL11A DSCAML1 LHX1 MEGF8 MYPN DIAPH1 LRP1 AUTS2 NKX6-1 ROBO3 | 6.48e-04 | 566 | 165 | 13 | GO:0007409 |
| GeneOntologyCellularComponent | actin cytoskeleton | ESPN AMPH WIPF1 MYO9B BAG3 SYNPO2L SYNPO FOXA3 SH2B2 AFAP1 XIRP2 FMN1 DIAPH1 PXN AUTS2 RFLNA MYO18B CCDC102A | 8.08e-07 | 576 | 166 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SFPQ DEAF1 TENT4A CECR2 MED14 CHD3 ICE1 BCL11A KAT2A DRAP1 KDM6B NCOR2 MLXIPL KMT2D SALL1 PELP1 CHTF18 NPAP1 FIP1L1 SMARCC2 MCRS1 TNKS POLD3 FOXH1 CPSF7 SYMPK HR | 1.16e-05 | 1377 | 166 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | actin filament | 2.22e-05 | 146 | 166 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | actin filament bundle | 4.42e-05 | 118 | 166 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.18e-04 | 96 | 166 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.14e-04 | 107 | 166 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.14e-04 | 107 | 166 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 3.46e-04 | 117 | 166 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | ATPase complex | 5.83e-04 | 129 | 166 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 6.17e-04 | 5 | 166 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | chromatin | FOXS1 CUX2 SFPQ DEAF1 CECR2 ARX CHD3 ICE1 BCL11A KAT2A FOXA3 CIC HOXA3 LHX1 NCOR2 MLXIPL SALL1 PELP1 SMARCC2 MCRS1 DMRTA1 NKX6-1 FOXH1 HR | 6.55e-04 | 1480 | 166 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | cell leading edge | EPS8 AMPH ABI1 WIPF1 RAPH1 MYO9B CARMIL3 HCN2 SH2B2 SH2B1 DIAPH1 PXN | 6.72e-04 | 500 | 166 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 1.12e-03 | 26 | 166 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | Z disc | 1.32e-03 | 151 | 166 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.72e-03 | 108 | 166 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.88e-03 | 31 | 166 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | axon | EPS8 AMPH ABI1 MAP1A ADGRL1 SYNPO LMTK3 HCN2 DSCAML1 MYPN LRP1 AUTS2 TNK2 SYT5 ROBO3 CNGB1 | 2.00e-03 | 891 | 166 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | I band | 2.14e-03 | 166 | 166 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | stereocilium | 2.22e-03 | 69 | 166 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | paraspeckles | 2.71e-03 | 10 | 166 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.01e-03 | 75 | 166 | 4 | GO:0035097 | |
| HumanPheno | Auditory sensitivity | 1.88e-05 | 37 | 47 | 5 | HP:0025112 | |
| HumanPheno | Hyperactivity | CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CC2D1A CHD3 KDM6B CIC SH2B1 MLXIPL NPAP1 AUTS2 SMARCC2 FOXH1 | 2.03e-05 | 558 | 47 | 16 | HP:0000752 |
| HumanPheno | Diagnostic behavioral phenotype | ESPN CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CHD3 BCL11A KDM6B CIC SH2B1 LHX1 KMT2D NPAP1 PCDH15 AUTS2 SMARCC2 | 5.53e-05 | 747 | 47 | 18 | HP:0025783 |
| HumanPheno | Hyperacusis | 1.11e-04 | 28 | 47 | 4 | HP:0010780 | |
| HumanPheno | Disinhibition | ABCA2 CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CC2D1A CHD3 BCL11A KDM6B CIC SH2B1 MLXIPL NPAP1 AUTS2 SMARCC2 FOXH1 | 1.56e-04 | 807 | 47 | 18 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ABCA2 CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CC2D1A CHD3 BCL11A KDM6B CIC SH2B1 MLXIPL NPAP1 AUTS2 SMARCC2 FOXH1 | 1.56e-04 | 807 | 47 | 18 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ABCA2 CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CC2D1A CHD3 BCL11A KDM6B CIC SH2B1 MLXIPL NPAP1 AUTS2 SMARCC2 FOXH1 | 1.56e-04 | 807 | 47 | 18 | HP:5200123 |
| HumanPheno | Social disinhibition | ABCA2 CUX2 DEAF1 DNAJC30 IQSEC2 ARX ADGRL1 CC2D1A CHD3 BCL11A KDM6B CIC SH2B1 MLXIPL NPAP1 AUTS2 SMARCC2 FOXH1 | 1.56e-04 | 807 | 47 | 18 | HP:5200029 |
| Domain | PH_dom-like | EPS8 RAPH1 NBEAL1 IQSEC2 ARHGEF18 ARHGEF17 SH2B2 SH2B1 ARHGEF15 AFAP1 TBC1D4 DGKK PHLPP1 IRS2 AGAP2 | 3.75e-06 | 426 | 159 | 15 | IPR011993 |
| Domain | FH2 | 6.42e-06 | 15 | 159 | 4 | PS51444 | |
| Domain | FH2_Formin | 6.42e-06 | 15 | 159 | 4 | IPR015425 | |
| Domain | FH2 | 6.42e-06 | 15 | 159 | 4 | PF02181 | |
| Domain | FH2 | 6.42e-06 | 15 | 159 | 4 | SM00498 | |
| Domain | PH_DOMAIN | EPS8 RAPH1 IQSEC2 ARHGEF18 SH2B2 SH2B1 AFAP1 DGKK PHLPP1 IRS2 AGAP2 | 2.78e-05 | 279 | 159 | 11 | PS50003 |
| Domain | PH_domain | EPS8 RAPH1 IQSEC2 ARHGEF18 SH2B2 SH2B1 AFAP1 DGKK PHLPP1 IRS2 AGAP2 | 2.87e-05 | 280 | 159 | 11 | IPR001849 |
| Domain | - | EPS8 RAPH1 IQSEC2 ARHGEF18 ARHGEF17 SH2B2 SH2B1 AFAP1 TBC1D4 DGKK PHLPP1 IRS2 AGAP2 | 3.11e-05 | 391 | 159 | 13 | 2.30.29.30 |
| Domain | DAD_dom | 3.29e-05 | 8 | 159 | 3 | IPR014767 | |
| Domain | DAD | 3.29e-05 | 8 | 159 | 3 | PS51231 | |
| Domain | PHD | 4.29e-05 | 75 | 159 | 6 | PF00628 | |
| Domain | Drf_GBD | 4.90e-05 | 9 | 159 | 3 | PF06371 | |
| Domain | Drf_FH3 | 4.90e-05 | 9 | 159 | 3 | PF06367 | |
| Domain | FH3_dom | 4.90e-05 | 9 | 159 | 3 | IPR010472 | |
| Domain | GTPase-bd | 4.90e-05 | 9 | 159 | 3 | IPR010473 | |
| Domain | Drf_FH3 | 4.90e-05 | 9 | 159 | 3 | SM01139 | |
| Domain | Drf_GBD | 4.90e-05 | 9 | 159 | 3 | SM01140 | |
| Domain | Znf_PHD-finger | 5.77e-05 | 79 | 159 | 6 | IPR019787 | |
| Domain | Paxillin | 7.20e-05 | 2 | 159 | 2 | IPR001904 | |
| Domain | GBD/FH3_dom | 9.50e-05 | 11 | 159 | 3 | IPR014768 | |
| Domain | GBD_FH3 | 9.50e-05 | 11 | 159 | 3 | PS51232 | |
| Domain | PHD | 1.12e-04 | 89 | 159 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.27e-04 | 91 | 159 | 6 | IPR001965 | |
| Domain | PH | RAPH1 IQSEC2 ARHGEF18 SH2B2 SH2B1 AFAP1 DGKK PHLPP1 IRS2 AGAP2 | 1.38e-04 | 278 | 159 | 10 | SM00233 |
| Domain | PH | 1.55e-04 | 229 | 159 | 9 | PF00169 | |
| Domain | ZF_PHD_2 | 1.61e-04 | 95 | 159 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.71e-04 | 96 | 159 | 6 | PS01359 | |
| Domain | AUTS2 | 2.15e-04 | 3 | 159 | 2 | IPR023246 | |
| Domain | Phe_ZIP | 2.15e-04 | 3 | 159 | 2 | PF08916 | |
| Domain | Phe_ZIP | 2.15e-04 | 3 | 159 | 2 | IPR015012 | |
| Domain | SH2B | 2.15e-04 | 3 | 159 | 2 | IPR030523 | |
| Domain | EGD2/NACA | 2.15e-04 | 3 | 159 | 2 | IPR016641 | |
| Domain | WH2 | 3.13e-04 | 16 | 159 | 3 | PF02205 | |
| Domain | NAC | 7.08e-04 | 5 | 159 | 2 | SM01407 | |
| Domain | WH2_dom | 7.19e-04 | 21 | 159 | 3 | IPR003124 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 1.06e-03 | 6 | 159 | 2 | IPR002715 | |
| Domain | SPOC_C | 1.06e-03 | 6 | 159 | 2 | IPR012921 | |
| Domain | NAC | 1.06e-03 | 6 | 159 | 2 | PF01849 | |
| Domain | NAC_AB | 1.06e-03 | 6 | 159 | 2 | PS51151 | |
| Domain | SPOC | 1.06e-03 | 6 | 159 | 2 | PF07744 | |
| Domain | PROTEIN_KINASE_DOM | SPEG KSR2 PKDCC ACVR2A LMTK3 PXK MAP3K10 TNK2 TRIB1 MAP4K2 WNK2 SBK3 | 1.07e-03 | 493 | 159 | 12 | PS50011 |
| Domain | WH2 | 1.07e-03 | 24 | 159 | 3 | PS51082 | |
| Domain | - | 1.23e-03 | 55 | 159 | 4 | 1.10.30.10 | |
| Domain | Pkinase | 1.61e-03 | 381 | 159 | 10 | PF00069 | |
| Domain | Znf_FYVE_PHD | 1.63e-03 | 147 | 159 | 6 | IPR011011 | |
| Domain | Homeodomain-like | 2.20e-03 | 332 | 159 | 9 | IPR009057 | |
| Domain | HMG_box_dom | 2.29e-03 | 65 | 159 | 4 | IPR009071 | |
| Domain | Kinase-like_dom | RAPH1 SPEG KSR2 PKDCC ACVR2A PXK MAP3K10 TNK2 TRIB1 MAP4K2 WNK2 SBK3 | 2.37e-03 | 542 | 159 | 12 | IPR011009 |
| Domain | CNMP_BINDING_1 | 2.51e-03 | 32 | 159 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.51e-03 | 32 | 159 | 3 | PS00889 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 LRFN1 ZNF48 MYO9B PPRC1 SPEG KSR2 FBRSL1 MED14 PER1 ADGRL1 CC2D1A ICE1 KAT2A KDM6B MBD6 ZNF865 SH2B2 CIC NCOR2 CELSR1 KMT2D MEGF8 TIGD3 PXN TNK2 MLLT6 IRS2 TRIB1 CEP170B WNK2 SYMPK HR | 4.98e-17 | 1105 | 169 | 33 | 35748872 |
| Pubmed | SFPQ LRFN1 ABI1 PRR36 IQSEC2 KSR2 RANBP9 ARHGEF18 DIDO1 SYNPO BCL11A LMTK3 HCN2 NCOR2 MAP7D1 PELP1 YLPM1 DIAPH1 LRP1 SMARCC2 TNKS PRRC2A CEP170B GOLGA3 WNK2 AGAP2 | 1.45e-12 | 963 | 169 | 26 | 28671696 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | SFPQ URI1 ABI1 WIPF1 TBC1D4 YLPM1 DIAPH1 FIP1L1 SMARCC2 FMNL1 CPSF7 SYMPK | 1.54e-11 | 154 | 169 | 12 | 16055720 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXS1 ABI1 PHF23 MYO9B PER1 DRAP1 FOXA3 CIC SH2B1 NCOR2 MAP7D1 KMT2D TBC1D4 SALL1 PELP1 LRP1 FIP1L1 SMARCC2 MCRS1 NKX6-1 FOXH1 TRIB1 SYMPK | 3.60e-11 | 857 | 169 | 23 | 25609649 |
| Pubmed | DEAF1 PHF23 NACA FBRSL1 DIDO1 CC2D1A CHD3 BCL11A KAT2A MBD6 CIC LHX1 NCOR2 MAP7D1 KMT2D SALL1 DGKK YLPM1 AUTS2 FIP1L1 SMARCC2 MCRS1 MLLT6 PRKCSH PRRC2A TRIB1 CPSF7 SYMPK | 3.27e-10 | 1429 | 169 | 28 | 35140242 | |
| Pubmed | RAPH1 BAG3 CHD3 ICE1 RBBP8NL CIC NCOR2 MAP7D1 KMT2D TBC1D4 SALL1 LRP1 PXN IRS2 GOLGA3 | 2.42e-09 | 418 | 169 | 15 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CUX2 MAP1A PHF23 ARHGEF18 LMTK3 CIC SH2B1 NCOR2 SALL1 XIRP2 YLPM1 TNK2 MLLT6 TNKS WNK2 | 3.54e-09 | 430 | 169 | 15 | 35044719 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DEAF1 RAPH1 BAG3 PHRF1 MED14 DIDO1 CHD3 CIC NCOR2 KMT2D TBC1D4 CHTF18 YLPM1 RBM15B FIP1L1 SMARCC2 IRS2 PRRC2A SYMPK | 8.70e-09 | 774 | 169 | 19 | 15302935 |
| Pubmed | MAP1A P3H3 TPRN CECR2 PHRF1 LPCAT4 RANBP9 FBRSL1 PER1 CHD3 BCL11A KAT2A FMNL2 NCOR2 MAP7D1 DIAPH1 LRP1 FIP1L1 SMARCC2 MCRS1 IRS2 CEP170B | 2.81e-08 | 1116 | 169 | 22 | 31753913 | |
| Pubmed | 1.22e-07 | 118 | 169 | 8 | 21078624 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SFPQ DEAF1 ZNF48 DIDO1 CHD3 ICE1 CIC NCOR2 SALL1 PELP1 YLPM1 RBM15B FIP1L1 SMARCC2 MLLT6 FOXH1 PRRC2A CPSF7 SYMPK | 2.28e-07 | 954 | 169 | 19 | 36373674 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RAPH1 BAG3 DIDO1 ICE1 MAP7D1 RBM15B FIP1L1 IRS2 MYO18B PRRC2A FMNL1 CPSF7 | 2.30e-07 | 361 | 169 | 12 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ABI1 RAPH1 IQSEC2 BAG3 CC2D1A LARP1B ARHGEF17 DENND2B CIC MLXIPL MAP7D1 TBC1D4 MEGF8 MAP3K10 FIP1L1 IRS2 CEP170B CCDC102A | 2.40e-07 | 861 | 169 | 18 | 36931259 |
| Pubmed | CUX2 URI1 DEAF1 ZNF48 PHF23 DIDO1 CHD3 KAT2A DRAP1 CIC TSC22D1 KRBA1 SALL1 PXN MLLT6 FOXH1 UTF1 | 4.84e-07 | 808 | 169 | 17 | 20412781 | |
| Pubmed | EPS8 AMPH SFPQ ABI1 MAP1A PRR36 IQSEC2 ADGRL1 SYNPO CHD3 BCL11A ARHGEF17 FMNL2 MLXIPL MAP7D1 AFAP1 SMARCC2 PRRC2A CEP170B GOLGA3 WNK2 AGAP2 CPSF7 | 5.04e-07 | 1431 | 169 | 23 | 37142655 | |
| Pubmed | Expression of multiple formins in adult tissues and during developmental stages of mouse brain. | 5.19e-07 | 14 | 169 | 4 | 26272686 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SFPQ ABI1 DEAF1 ARX ADGRL1 SYNPO BCL11A MEGF8 SMARCC2 SYT5 MCRS1 PRKCSH ANKRD40 GOLGA3 | 7.00e-07 | 560 | 169 | 14 | 21653829 |
| Pubmed | SFPQ WIPF1 MAP1A BAG3 RANBP9 ADGRL1 SYNPO FMNL2 CIC TSC22D1 MAP3K10 TNK2 WNK2 | 8.40e-07 | 486 | 169 | 13 | 20936779 | |
| Pubmed | SFPQ TPRN RANBP9 CHD3 FMNL2 DENND2B NCOR2 KMT2D PELP1 GORASP1 YLPM1 DIAPH1 LRP1 FMNL1 | 1.32e-06 | 591 | 169 | 14 | 15231748 | |
| Pubmed | ABCA2 CECR2 NACA PHRF1 FBRSL1 DIDO1 SYNPO ICE1 KDM6B NACAD AFAP1 AUTS2 WNK2 | 2.14e-06 | 529 | 169 | 13 | 14621295 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXS1 CUX2 DEAF1 ARX DRAP1 FOXA3 CIC HOXA3 BCL6B MLXIPL TSC22D1 KMT2D SALL1 DMRTA1 NKX6-1 FOXH1 TOX2 | 2.36e-06 | 908 | 169 | 17 | 19274049 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | EPS8 AMPH LRFN1 DEAF1 MYO9B DUSP8 RANBP9 CC2D1A CHD3 ICE1 DRAP1 KDM6B NACAD CIC TSC22D1 GORASP1 SYT5 PRKCSH MAP4K2 | 2.60e-06 | 1124 | 169 | 19 | 21900206 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.56e-06 | 184 | 169 | 8 | 32908313 | |
| Pubmed | 6.28e-06 | 25 | 169 | 4 | 25108383 | ||
| Pubmed | SFPQ DEAF1 WIPF1 MED14 DIDO1 CC2D1A CHD3 BCL11A KAT2A CIC NCOR2 MAP7D1 KMT2D FIP1L1 SMARCC2 MLLT6 PRRC2A CPSF7 | 7.84e-06 | 1103 | 169 | 18 | 34189442 | |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 35296311 | ||
| Pubmed | 1.01e-05 | 152 | 169 | 7 | 38360978 | ||
| Pubmed | 1.25e-05 | 157 | 169 | 7 | 30186101 | ||
| Pubmed | 1.32e-05 | 220 | 169 | 8 | 24550385 | ||
| Pubmed | ABCA2 PPRC1 IQSEC2 RANBP9 ZBTB47 SYNPO KDM6B FMNL2 DSCAML1 SH2B1 YLPM1 LRP1 MAP3K10 FIP1L1 MCRS1 TNKS PRRC2A GOLGA3 AGAP2 | 1.72e-05 | 1285 | 169 | 19 | 35914814 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.87e-05 | 231 | 169 | 8 | 16452087 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFPQ DEAF1 ZNF48 PHRF1 DIDO1 CHD3 KAT2A CIC NCOR2 MLXIPL MAP7D1 KMT2D PELP1 YLPM1 RBM15B FIP1L1 MCRS1 CPSF7 SYMPK | 1.90e-05 | 1294 | 169 | 19 | 30804502 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CABLES2 EPS8 CARMIL3 DRAP1 LMTK3 NCOR2 FMN1 KANK4 TNKS PRRC2A FMNL1 | 2.29e-05 | 475 | 169 | 11 | 31040226 |
| Pubmed | Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. | 2.35e-05 | 2 | 169 | 2 | 21118970 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14990563 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30744518 | ||
| Pubmed | Formin-1 protein associates with microtubules through a peptide domain encoded by exon-2. | 2.35e-05 | 2 | 169 | 2 | 16480715 | |
| Pubmed | Differential role of SH2-B and APS in regulating energy and glucose homeostasis. | 2.35e-05 | 2 | 169 | 2 | 16455776 | |
| Pubmed | Regulation of actin cytoskeleton architecture by Eps8 and Abi1. | 2.35e-05 | 2 | 169 | 2 | 16225669 | |
| Pubmed | Formins regulate actin filament flexibility through long range allosteric interactions. | 2.35e-05 | 2 | 169 | 2 | 16490788 | |
| Pubmed | A genome-wide association study reveals 2 new susceptibility loci for atopic dermatitis. | 2.35e-05 | 2 | 169 | 2 | 25865352 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34031495 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16943183 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34493754 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23572530 | ||
| Pubmed | Critical roles for multiple formins during cardiac myofibril development and repair. | 2.35e-05 | 2 | 169 | 2 | 24430873 | |
| Pubmed | Formin and capping protein together embrace the actin filament in a ménage à trois. | 2.35e-05 | 2 | 169 | 2 | 26564775 | |
| Pubmed | CECR2 NACA ZBTB47 DIDO1 ZNF865 NCOR2 MAP7D1 SALL1 PCDH15 SMARCC2 | 2.62e-05 | 396 | 169 | 10 | 26687479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EPS8 MAP1A MYO9B TPRN FBRSL1 CIC NCOR2 TBC1D4 SALL1 DIAPH1 CEP170B CPSF7 | 3.35e-05 | 588 | 169 | 12 | 38580884 |
| Pubmed | 3.94e-05 | 14 | 169 | 3 | 9921901 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN CABLES2 URI1 KSR2 FBRSL1 ARHGEF18 ADGRL1 SYNPO CHD3 RBBP8NL DENND2B SH2B1 NCOR2 TSC22D1 TBC1D4 LRP1 AUTS2 TNK2 CEP170B WNK2 | 3.99e-05 | 1489 | 169 | 20 | 28611215 |
| Pubmed | AMPH SFPQ ABI1 MAP1A IQSEC2 NACA RANBP9 PER1 ADGRL1 SYNPO NACAD MAP3K10 SMARCC2 POLD3 CEP170B WNK2 AGAP2 | 4.36e-05 | 1139 | 169 | 17 | 36417873 | |
| Pubmed | 4.91e-05 | 15 | 169 | 3 | 28536193 | ||
| Pubmed | Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2. | 4.91e-05 | 15 | 169 | 3 | 19144635 | |
| Pubmed | 4.91e-05 | 15 | 169 | 3 | 16417406 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TEPSIN URI1 RAPH1 IQSEC2 FBRSL1 PER1 CC2D1A MLXIPL GORASP1 MYPN PXN FIP1L1 MCRS1 TNKS IRS2 POLD3 | 5.07e-05 | 1038 | 169 | 16 | 26673895 |
| Pubmed | 5.37e-05 | 268 | 169 | 8 | 33640491 | ||
| Pubmed | 5.45e-05 | 347 | 169 | 9 | 17114649 | ||
| Pubmed | 6.03e-05 | 16 | 169 | 3 | 33253712 | ||
| Pubmed | 6.26e-05 | 202 | 169 | 7 | 24639526 | ||
| Pubmed | Regulation of cell-cell adhesion by Abi/Diaphanous complexes. | 7.02e-05 | 3 | 169 | 2 | 19158278 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 39430739 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 30309655 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 22328058 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 10499589 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 25447542 | ||
| Pubmed | SH2-B family members differentially regulate JAK family tyrosine kinases. | 7.02e-05 | 3 | 169 | 2 | 11751854 | |
| Pubmed | [Molecular mechanism of SH2B1 in regulating JAK2/IRS2 during obesity development]. | 7.02e-05 | 3 | 169 | 2 | 20360640 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 14766215 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 19542202 | ||
| Pubmed | Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. | 7.02e-05 | 3 | 169 | 2 | 12684686 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 19102128 | ||
| Pubmed | Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. | 7.02e-05 | 3 | 169 | 2 | 9010225 | |
| Pubmed | Lhx1/5 control dendritogenesis and spine morphogenesis of Purkinje cells via regulation of Espin. | 7.02e-05 | 3 | 169 | 2 | 28516904 | |
| Pubmed | Mechanistic differences in actin bundling activity of two mammalian formins, FRL1 and mDia2. | 7.02e-05 | 3 | 169 | 2 | 16556604 | |
| Pubmed | The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. | 7.02e-05 | 3 | 169 | 2 | 26551667 | |
| Pubmed | The filamentous actin cross-linking/bundling activity of mammalian formins. | 7.02e-05 | 3 | 169 | 2 | 18835565 | |
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 15289329 | ||
| Pubmed | 7.21e-05 | 360 | 169 | 9 | 33111431 | ||
| Pubmed | 7.75e-05 | 209 | 169 | 7 | 36779422 | ||
| Pubmed | Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development. | 8.72e-05 | 18 | 169 | 3 | 23201013 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.07e-04 | 220 | 169 | 7 | 35785414 | |
| Pubmed | A quantitative survey of gravity receptor function in mutant mouse strains. | 1.21e-04 | 20 | 169 | 3 | 16235133 | |
| Pubmed | EPS8 ABI1 ZNF48 NACA PHRF1 MED14 DIDO1 ICE1 KAT2A CIC CELSR1 MAP7D1 AFAP1 RBM15B PXN TMEM266 MCRS1 PRRC2A CEP170B | 1.32e-04 | 1497 | 169 | 19 | 31527615 | |
| Pubmed | SFPQ PHF23 MED14 DIDO1 CHD3 KAT2A NCOR2 CHTF18 YLPM1 DIAPH1 FIP1L1 SMARCC2 POLD3 CPSF7 SYMPK | 1.38e-04 | 1014 | 169 | 15 | 32416067 | |
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 21888672 | ||
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 11827956 | ||
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 16129689 | ||
| Pubmed | The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. | 1.40e-04 | 4 | 169 | 2 | 11099046 | |
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 17597063 | ||
| Pubmed | Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea. | 1.40e-04 | 4 | 169 | 2 | 16972005 | |
| Pubmed | Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants. | 1.40e-04 | 4 | 169 | 2 | 28213671 | |
| Pubmed | Paxillin Is Required for Proper Spinal Motor Axon Growth into the Limb. | 1.40e-04 | 4 | 169 | 2 | 33727334 | |
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 19251705 | ||
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 12127568 | ||
| Pubmed | 1.40e-04 | 4 | 169 | 2 | 19564905 | ||
| Pubmed | Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. | 1.40e-04 | 4 | 169 | 2 | 24358267 | |
| Pubmed | 4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass. | 1.40e-04 | 4 | 169 | 2 | 27217487 | |
| Pubmed | Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. | 1.40e-04 | 4 | 169 | 2 | 29276085 | |
| Pubmed | Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. | 1.40e-04 | 4 | 169 | 2 | 19293402 | |
| Interaction | NCK2 interactions | ABI1 WIPF1 RAPH1 GGN SYNPO BCL11A DRAP1 RBBP8NL MBD6 SOCS7 YLPM1 PXN TNK2 PRRC2A CPSF7 | 3.71e-09 | 262 | 163 | 15 | int:NCK2 |
| Interaction | TOP3B interactions | ABCA2 LRFN1 ZNF48 MYO9B PPRC1 SPEG KSR2 FBRSL1 MED14 PER1 ADGRL1 CC2D1A ICE1 KAT2A KDM6B MBD6 ZNF865 SH2B2 CIC NCOR2 CELSR1 KMT2D MEGF8 PELP1 TIGD3 PXN TNK2 MLLT6 IRS2 PRRC2A TRIB1 CEP170B WNK2 SYMPK HR | 5.65e-09 | 1470 | 163 | 35 | int:TOP3B |
| Interaction | PRMT2 interactions | 5.28e-08 | 91 | 163 | 9 | int:PRMT2 | |
| Interaction | SORBS2 interactions | 3.36e-06 | 111 | 163 | 8 | int:SORBS2 | |
| Interaction | TLE3 interactions | CECR2 FBRSL1 FOXA3 CIC NCOR2 KMT2D TBC1D4 SALL1 AUTS2 SMARCC2 MLLT6 ANKRD40 CPSF7 | 1.22e-05 | 376 | 163 | 13 | int:TLE3 |
| Interaction | GAS7 interactions | 1.32e-05 | 38 | 163 | 5 | int:GAS7 | |
| Interaction | P4HA2 interactions | 1.68e-05 | 138 | 163 | 8 | int:P4HA2 | |
| Interaction | SH3RF1 interactions | 2.80e-05 | 108 | 163 | 7 | int:SH3RF1 | |
| Interaction | GRB2 interactions | EPS8 WIPF1 MAP1A GGN DUSP8 BAG3 HCN2 SH2B2 SH2B1 SOCS7 MLXIPL YLPM1 DIAPH1 PXN FIP1L1 TNK2 IRS2 PRRC2A CPSF7 | 2.93e-05 | 806 | 163 | 19 | int:GRB2 |
| Interaction | FMR1 interactions | SFPQ CECR2 IQSEC2 BAG3 RANBP9 ARHGEF18 CHD3 BCL11A LMTK3 NCOR2 LRP1 SMARCC2 PRRC2A CEP170B AGAP2 | 3.13e-05 | 536 | 163 | 15 | int:FMR1 |
| Interaction | FXR1 interactions | FOXS1 SFPQ ABI1 DEAF1 CECR2 RANBP9 DIDO1 LARP1B LMTK3 NCOR2 SMARCC2 MCRS1 PRKCSH ANKRD40 PRRC2A CEP170B GOLGA3 | 3.75e-05 | 679 | 163 | 17 | int:FXR1 |
| Interaction | CACNA1A interactions | 6.44e-05 | 123 | 163 | 7 | int:CACNA1A | |
| Interaction | PRPF40A interactions | SFPQ ABI1 WIPF1 CHD3 FMNL2 PELP1 FMN1 YLPM1 DIAPH1 FIP1L1 SMARCC2 FMNL1 CPSF7 | 7.15e-05 | 446 | 163 | 13 | int:PRPF40A |
| Interaction | GSC interactions | 7.51e-05 | 87 | 163 | 6 | int:GSC | |
| Interaction | KDM1A interactions | RAPH1 BAG3 RANBP9 CHD3 ICE1 RBBP8NL CIC NCOR2 MAP7D1 KMT2D TBC1D4 PELP1 LRP1 PXN TMEM266 SMARCC2 MCRS1 IRS2 GOLGA3 SYMPK | 7.59e-05 | 941 | 163 | 20 | int:KDM1A |
| Interaction | HDAC1 interactions | SFPQ RAPH1 PHF23 BAG3 RANBP9 CHD3 BCL11A CIC BCL6B NCOR2 MAP7D1 KMT2D TBC1D4 SALL1 PXN PHLPP1 SMARCC2 IRS2 POLD3 GOLGA3 SYMPK HR | 8.83e-05 | 1108 | 163 | 22 | int:HDAC1 |
| Interaction | GOLGA2 interactions | TEPSIN ZNF48 GGN SYNPO2L ICE1 BCL11A CIC BCL6B NCOR2 KMT2D SALL1 GORASP1 PHLPP1 FIP1L1 MCRS1 MLLT6 GOLGA3 | 9.61e-05 | 733 | 163 | 17 | int:GOLGA2 |
| Interaction | NR2F1 interactions | 1.06e-04 | 58 | 163 | 5 | int:NR2F1 | |
| Interaction | TSEN2 interactions | 1.15e-04 | 59 | 163 | 5 | int:TSEN2 | |
| Interaction | PRELP interactions | 1.24e-04 | 32 | 163 | 4 | int:PRELP | |
| Cytoband | 17p13.1 | 3.02e-07 | 118 | 169 | 7 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 4.68e-05 | 346 | 169 | 8 | chr17p13 | |
| Cytoband | Xp11.22 | 4.85e-05 | 54 | 169 | 4 | Xp11.22 | |
| Cytoband | 5p15 | 2.79e-04 | 7 | 169 | 2 | 5p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LRFN1 GGN LMTK3 FOXA3 ZNF865 CIC CGB2 MEGF8 MAMSTR MAP3K10 SYT5 SBK3 SYMPK | 5.04e-04 | 1192 | 169 | 13 | chr19q13 |
| Cytoband | 16p11.2 | 7.38e-04 | 191 | 169 | 5 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 9.23e-04 | 415 | 169 | 7 | chr12q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.03e-03 | 423 | 169 | 7 | chr12q13 | |
| Cytoband | 17q21 | 1.65e-03 | 63 | 169 | 3 | 17q21 | |
| GeneFamily | PHD finger proteins | 1.32e-05 | 90 | 104 | 6 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.50e-05 | 206 | 104 | 8 | 682 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.25e-04 | 181 | 104 | 6 | 694 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.43e-03 | 10 | 104 | 2 | 250 | |
| GeneFamily | Forkhead boxes | 1.93e-03 | 43 | 104 | 3 | 508 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.38e-03 | 161 | 104 | 5 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | 2.75e-03 | 242 | 104 | 6 | 403 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPH1 SPEG KSR2 LPCAT4 ADGRL1 CHD3 BCL11A ACVR2A LARP1B SEZ6L2 FMNL2 DSCAML1 PXK SOCS7 LHX1 AUTS2 SMARCC2 TNK2 TNKS TOX2 GOLGA3 | 6.63e-06 | 1106 | 165 | 21 | M39071 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | CARMIL3 PKDCC ADGRL1 KDM6B MBD6 SEZ6L2 MLXIPL TSC22D1 NKX6-1 | 8.42e-06 | 212 | 165 | 9 | MM3816 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | AMPH SPEG KSR2 BCL11A ACVR2A LARP1B LMTK3 SEZ6L2 LHX1 AUTS2 HS3ST4 TOX2 CNGB1 | 8.42e-06 | 465 | 165 | 13 | M39066 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | TEPSIN MYO9B PPRC1 FBRSL1 CIC KMT2D RBM15B TNK2 PRRC2A CPSF7 SYMPK | 1.05e-05 | 338 | 165 | 11 | M17094 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | EPS8 AMPH ABCA2 P3H3 SPEG PER1 SYNPO SEZ6L2 HOXA3 CSF2RB GOLGA3 | 1.66e-05 | 355 | 165 | 11 | M45758 |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | GPR137 DNAJC30 IQSEC2 PER1 ADGRL1 DIDO1 CHD3 DRAP1 KDM6B HCN2 SEZ6L2 MEGF8 PELP1 LRP1 AUTS2 MAP3K10 TNK2 HS3ST4 | 3.44e-05 | 954 | 165 | 18 | MM3689 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CARMIL3 FBRSL1 SEZ6L2 CIC NCOR2 AFAP1 AUTS2 SYT5 PRKCSH GOLGA3 AGAP2 | 3.82e-05 | 389 | 165 | 11 | M39102 |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 3.84e-05 | 198 | 165 | 8 | M3116 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN | 4.12e-05 | 200 | 165 | 8 | M8331 | |
| Coexpression | BURTON_ADIPOGENESIS_1 | 4.17e-05 | 31 | 165 | 4 | M1612 | |
| Coexpression | BURTON_ADIPOGENESIS_1 | 4.17e-05 | 31 | 165 | 4 | MM1191 | |
| Coexpression | PDGF_ERK_DN.V1_DN | 4.57e-05 | 149 | 165 | 7 | M2828 | |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_DN | 5.17e-05 | 12 | 165 | 3 | M1408 | |
| Coexpression | ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR | 8.47e-05 | 14 | 165 | 3 | MM1246 | |
| Coexpression | ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR | 8.47e-05 | 14 | 165 | 3 | M1862 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | CUX2 ZNF48 PRR36 CARMIL3 DUSP8 ARX BCL11A LMTK3 SH2B2 NACAD HOXA3 CELSR1 AFAP1 AUTS2 DMRTA1 IRS2 ROBO3 TOX2 WNK2 AGAP2 | 1.09e-06 | 727 | 166 | 20 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | AMPH ABCA2 CUX2 PPRC1 SPEG KSR2 PHRF1 DRAP1 LMTK3 KDM6B MBD6 ZNF865 SH2B1 MLXIPL CELSR1 CHTF18 DGKK MCRS1 MLLT6 SLC16A11 IRS2 PRKCSH PRRC2A TRIB1 CEP170B WNK2 SYMPK | 2.12e-06 | 1275 | 166 | 27 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | ESPN AMPH ABCA2 CUX2 ZNF48 PRR36 CECR2 DUSP8 KSR2 FBRSL1 BCL11A ACVR2A LMTK3 RBBP8NL SEZ6L2 FMNL2 DSCAML1 MLXIPL CELSR1 SALL1 AUTS2 TMEM266 PHLPP1 SYT5 SLC16A11 IRS2 TOX2 CEP170B WNK2 | 2.73e-06 | 1453 | 166 | 29 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | ABCA2 CUX2 MAP1A PRR36 CARMIL3 CECR2 ARX BCL11A FMNL2 MLXIPL SALL1 PHLPP1 SLC16A11 TOX2 WNK2 | 8.61e-06 | 496 | 166 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K1 | AMPH CUX2 PPRC1 CECR2 DUSP8 PKDCC ZBTB47 ADGRL1 LMTK3 KDM6B SEZ6L2 MLXIPL CELSR1 CHTF18 DGKK SYT5 MCRS1 SLC16A11 IRS2 TRIB1 SYMPK | 3.66e-05 | 1000 | 166 | 21 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K0 | AMPH ABCA2 CUX2 ZNF48 CECR2 DUSP8 BCL11A ACVR2A LMTK3 SEZ6L2 FMNL2 MLXIPL CELSR1 SALL1 AUTS2 PHLPP1 SYT5 SLC16A11 IRS2 WNK2 | 3.85e-05 | 926 | 166 | 20 | facebase_RNAseq_e10.5_OlfacPit_2500_K0 |
| CoexpressionAtlas | cerebral cortex | AMPH ABCA2 CUX2 LRFN1 MAP1A PRR36 CARMIL3 CECR2 DUSP8 KSR2 ADGRL1 LMTK3 HCN2 SEZ6L2 FMNL2 NACAD DSCAML1 KCNH4 PCDH15 MAP3K10 TMEM266 SYT5 INSYN2B HS3ST4 TMEM200C AGAP2 | 4.67e-05 | 1428 | 166 | 26 | cerebral cortex |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.70e-05 | 121 | 166 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | AMPH ABCA2 CUX2 ZNF48 MAP1A PRR36 FBRSL1 MED14 BCL11A LMTK3 FMNL2 MLXIPL CELSR1 SALL1 DGKK RBM15B AUTS2 PHLPP1 FIP1L1 SYT5 SLC16A11 IRS2 POLD3 TOX2 WNK2 | 6.41e-05 | 1370 | 166 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MAP1A PRR36 CARMIL3 CECR2 ARX ZBTB47 SYNPO BCL11A ACVR2A FMNL2 LHX1 SALL1 PHLPP1 MLLT6 DMRTA1 SLC16A11 POLD3 ROBO3 TOX2 WNK2 | 8.76e-05 | 983 | 166 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | GPR137 PPRC1 CECR2 LPCAT4 RANBP9 MED14 ICE1 LMTK3 ST6GALNAC6 MBD6 KRBA1 MAP7D1 SALL1 FMN1 DGKK DIAPH1 KANK4 MLLT6 TOX2 TRIB1 | 8.76e-05 | 983 | 166 | 20 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 1.36e-04 | 100 | 166 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | CUX2 TENT4A PRR36 ARHGEF18 CHD3 BCL11A NCOR2 MLXIPL MAMSTR TOX2 | 1.53e-04 | 306 | 166 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.07e-04 | 108 | 166 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | EPS8 ABCA2 CUX2 MAP1A PRR36 CECR2 ARX SYNPO CHD3 BCL11A SALL1 CSF2RB DGKK PCDH15 DMRTA1 ROBO3 TOX2 FMNL1 CEP170B | 2.34e-04 | 976 | 166 | 19 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ABCA2 CUX2 MAP1A PRR36 CARMIL3 CECR2 ARX MED14 CHD3 BCL11A FMNL2 MLXIPL CELSR1 SALL1 PHLPP1 SLC16A11 TOX2 TRIB1 WNK2 | 2.65e-04 | 986 | 166 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.71e-04 | 212 | 166 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | URI1 PRR36 CECR2 LPCAT4 RANBP9 ARHGEF18 BCL11A LHX1 MLXIPL KRBA1 MAP7D1 FMN1 YLPM1 DIAPH1 KANK4 SMARCC2 ROBO3 TOX2 FMNL1 | 2.76e-04 | 989 | 166 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCA2 CUX2 MAP1A PRR36 CARMIL3 CECR2 ADGRL1 CHD3 LMTK3 PXK MLXIPL MAMSTR SLC16A11 ROBO3 WNK2 | 3.40e-04 | 688 | 166 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.58e-04 | 221 | 166 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-09 | 189 | 169 | 10 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-08 | 186 | 169 | 9 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-06 | 167 | 169 | 7 | 6c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-06 | 168 | 169 | 7 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-06 | 178 | 169 | 7 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 185 | 169 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 188 | 169 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.75e-06 | 188 | 169 | 7 | e7681efb4d2de7f1d8a89552fff76a829376bf1b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 8.72e-06 | 126 | 169 | 6 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.19e-06 | 193 | 169 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | facs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 21cfcb751e548591fc8724a8329c294da6012e0f | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.09e-05 | 198 | 169 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 198 | 169 | 7 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 135 | 169 | 6 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 142 | 169 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 142 | 169 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-05 | 161 | 169 | 6 | bd520c9a1927d5d5355b4421e6b90b58bfb76a42 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-05 | 161 | 169 | 6 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.75e-05 | 163 | 169 | 6 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 163 | 169 | 6 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.88e-05 | 164 | 169 | 6 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 164 | 169 | 6 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 167 | 169 | 6 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 167 | 169 | 6 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 168 | 169 | 6 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.59e-05 | 169 | 169 | 6 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-05 | 169 | 169 | 6 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.59e-05 | 169 | 169 | 6 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.74e-05 | 170 | 169 | 6 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.74e-05 | 170 | 169 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 170 | 169 | 6 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 171 | 169 | 6 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 171 | 169 | 6 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 172 | 169 | 6 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 173 | 169 | 6 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 5.39e-05 | 174 | 169 | 6 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 5.57e-05 | 175 | 169 | 6 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.93e-05 | 177 | 169 | 6 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 177 | 169 | 6 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 6.12e-05 | 178 | 169 | 6 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.12e-05 | 178 | 169 | 6 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 6.31e-05 | 179 | 169 | 6 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 179 | 169 | 6 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 6.51e-05 | 180 | 169 | 6 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 181 | 169 | 6 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 181 | 169 | 6 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-05 | 182 | 169 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.13e-05 | 183 | 169 | 6 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 7.13e-05 | 183 | 169 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 7.13e-05 | 183 | 169 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.13e-05 | 113 | 169 | 5 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 184 | 169 | 6 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 184 | 169 | 6 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.57e-05 | 185 | 169 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.57e-05 | 185 | 169 | 6 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 7.57e-05 | 185 | 169 | 6 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-05 | 186 | 169 | 6 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 7.80e-05 | 186 | 169 | 6 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-05 | 186 | 169 | 6 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 187 | 169 | 6 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 187 | 169 | 6 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 189 | 169 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 190 | 169 | 6 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.77e-05 | 190 | 169 | 6 | b4dfc41f5a630140cab8b1b86de85de0f5b25e4a | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.77e-05 | 190 | 169 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-05 | 191 | 169 | 6 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 9.02e-05 | 191 | 169 | 6 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.02e-05 | 191 | 169 | 6 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 9.02e-05 | 191 | 169 | 6 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-05 | 191 | 169 | 6 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-05 | 191 | 169 | 6 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.29e-05 | 192 | 169 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 192 | 169 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | 18e11d515147accef9aee26e934b358b445e18e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | 7766f495f2f945802ef9a5b994cd00bb64d0dfe3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 193 | 169 | 6 | ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.83e-05 | 194 | 169 | 6 | d2f6c8900b5c448eede8047ca964e94b19bd6ca5 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.01e-04 | 195 | 169 | 6 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 195 | 169 | 6 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass | 1.04e-04 | 196 | 169 | 6 | 03b79f237e4f7ebab46b277d05377569c6342cf7 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 196 | 169 | 6 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype | 1.04e-04 | 196 | 169 | 6 | e8b12b046d42a58e6f4d9419ab05a5c55e764f34 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 196 | 169 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 196 | 169 | 6 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 196 | 169 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 196 | 169 | 6 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 196 | 169 | 6 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 123 | 169 | 5 | e0130010aa406d4e9d8f16ad32858c382277eeb2 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.07e-04 | 197 | 169 | 6 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 1.07e-04 | 197 | 169 | 6 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.15e-05 | 193 | 164 | 9 | 3262_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.30e-05 | 196 | 164 | 9 | 2783_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.30e-05 | 196 | 164 | 9 | 1301_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.30e-05 | 196 | 164 | 9 | 7222_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 2766_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 5515_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 4791_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 2644_UP | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 1.46e-05 | 199 | 164 | 9 | 578_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.52e-05 | 200 | 164 | 9 | 5626_UP | |
| Drug | Methamphetamine | DEAF1 MAP1A SCARF2 SPEG PHRF1 PER1 ICE1 KAT2A LMTK3 KDM6B CIC ARHGEF15 NCOR2 TBC1D4 CHTF18 LRP1 PXN PHLPP1 MLLT6 SLC16A11 MYO18B HS3ST4 MAP4K2 HR | 6.82e-05 | 1401 | 164 | 24 | ctd:D008694 |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 7.86e-05 | 192 | 164 | 8 | 4129_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.15e-05 | 193 | 164 | 8 | 5986_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 5630_DN | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 8.45e-05 | 194 | 164 | 8 | 440_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 4492_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 1214_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 9.08e-05 | 196 | 164 | 8 | 1294_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 9.08e-05 | 196 | 164 | 8 | 7502_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 3886_DN | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 4266_UP | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 6018_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 3364_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 1215_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 4800_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 2847_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 1650_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 7035_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 5335_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 164 | 8 | 3477_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 164 | 8 | 7463_UP | |
| Drug | methenamine silver | 1.08e-04 | 201 | 164 | 8 | CID000004101 | |
| Disease | hematocrit | RAPH1 NBEAL1 FBRSL1 PKDCC SYNPO CHD3 BCL11A RBBP8NL DENND2B PXK ARHGEF15 NCOR2 ANKRD33 TBC1D4 SALL1 FMN1 DGKK MAMSTR IRS2 POLD3 TRIB1 | 1.81e-07 | 1011 | 162 | 21 | EFO_0004348 |
| Disease | hypospadias | 6.20e-05 | 39 | 162 | 4 | EFO_0004209 | |
| Disease | Apraxia of Phonation | 8.95e-05 | 3 | 162 | 2 | C0264611 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.06e-04 | 195 | 162 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | FOXS1 CUX2 MYO9B FBRSL1 FOXA3 SH2B1 ARHGEF15 MLXIPL KRBA1 TBC1D4 CHTF18 DMRTA1 IRS2 RFLNA TOX2 TRIB1 CCDC102A | 1.30e-04 | 1105 | 162 | 17 | EFO_0004528 |
| Disease | Smith-Magenis syndrome | 1.78e-04 | 4 | 162 | 2 | C0795864 | |
| Disease | triglyceride measurement, coronary artery disease | 1.78e-04 | 4 | 162 | 2 | EFO_0001645, EFO_0004530 | |
| Disease | Paroxysmal atrial fibrillation | 2.30e-04 | 156 | 162 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 2.30e-04 | 156 | 162 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.30e-04 | 156 | 162 | 6 | C2585653 | |
| Disease | body surface area | TENT4A MYO9B SPATA31C2 PER1 DIDO1 SPATA31C1 NCOR2 MAP7D1 AUTS2 POLD3 TRIB1 SYMPK | 2.39e-04 | 643 | 162 | 12 | EFO_0022196 |
| Disease | Atrial Fibrillation | 2.64e-04 | 160 | 162 | 6 | C0004238 | |
| Disease | probable ATP-dependent RNA helicase DHX58 measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0802901 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.15e-04 | 59 | 162 | 4 | EFO_0022248 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.36e-04 | 60 | 162 | 4 | EFO_0022330 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 4.30e-04 | 64 | 162 | 4 | EFO_0022253 | |
| Disease | renal overload-type gout | 4.43e-04 | 6 | 162 | 2 | EFO_0021525 | |
| Disease | mean reticulocyte volume | RAPH1 MYO9B PPRC1 FBRSL1 BCL11A KAT2A SH2B1 MLXIPL TBC1D4 CHTF18 IRS2 RFLNA TRIB1 | 4.90e-04 | 799 | 162 | 13 | EFO_0010701 |
| Disease | testosterone measurement | CUX2 MAP1A MYO9B TPRN CECR2 IQSEC2 KDM6B FOXA3 SH2B1 ARHGEF15 NCOR2 MLXIPL CGB2 DGKK MYPN AUTS2 HS3ST4 | 6.74e-04 | 1275 | 162 | 17 | EFO_0004908 |
| Disease | free cholesterol to total lipids in large LDL percentage | 7.47e-04 | 74 | 162 | 4 | EFO_0022280 | |
| Disease | eosinophil cationic protein measurement | 8.21e-04 | 8 | 162 | 2 | EFO_0010913 | |
| Disease | Nonsyndromic genetic hearing loss | 8.26e-04 | 76 | 162 | 4 | cv:C5680182 | |
| Disease | sphingomyelin measurement | 9.01e-04 | 278 | 162 | 7 | EFO_0010118 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 9.98e-04 | 206 | 162 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | longitudinal alcohol consumption measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0007645 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.05e-03 | 9 | 162 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 1.07e-03 | 371 | 162 | 8 | EFO_0000275 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.10e-03 | 37 | 162 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.53e-03 | 224 | 162 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | colorectal cancer, colorectal adenoma | 1.55e-03 | 152 | 162 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | revision of total hip arthroplasty, aseptic loosening | 1.59e-03 | 42 | 162 | 3 | EFO_0010725, EFO_0020973 | |
| Disease | body weight | GPR137 CUX2 TENT4A NBEAL1 KSR2 SPATA31C2 SPATA31C1 SH2B1 MAP7D1 DGKK PCDH15 AUTS2 DMRTA1 SLC16A11 POLD3 TRIB1 | 1.62e-03 | 1261 | 162 | 16 | EFO_0004338 |
| Disease | multiple sclerosis | ESPN TENT4A FCRLA DRAP1 NCOR2 CSF2RB MAMSTR DMRTA1 TOX2 AGAP2 | 1.71e-03 | 594 | 162 | 10 | MONDO_0005301 |
| Disease | Gastric Adenocarcinoma | 1.95e-03 | 45 | 162 | 3 | C0278701 | |
| Disease | lifestyle measurement | 1.95e-03 | 235 | 162 | 6 | EFO_0010724 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.04e-03 | 97 | 162 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | uric acid measurement | CUX2 FBRSL1 ACVR2A DRAP1 MLXIPL ANKRD33 FMN1 TMEM266 TRIB1 MAP4K2 | 2.07e-03 | 610 | 162 | 10 | EFO_0004761 |
| Disease | egg allergy measurement, parental genotype effect measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.28e-03 | 166 | 162 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | phosphoglycerides measurement | 2.34e-03 | 48 | 162 | 3 | EFO_0022291 | |
| Disease | hemoglobin A1 measurement | 2.40e-03 | 520 | 162 | 9 | EFO_0007629 | |
| Disease | sleep duration, triglyceride measurement | 2.63e-03 | 104 | 162 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.64e-03 | 50 | 162 | 3 | EFO_0022334 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.79e-03 | 51 | 162 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.79e-03 | 51 | 162 | 3 | EFO_0022331 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.79e-03 | 51 | 162 | 3 | cv:CN043650 | |
| Disease | eosinophil percentage of leukocytes | ARHGEF18 KDM6B FOXA3 MLXIPL CELSR1 SALL1 CSF2RB PELP1 TOX2 TRIB1 SYMPK | 2.86e-03 | 746 | 162 | 11 | EFO_0007991 |
| Disease | fatty acid measurement | 2.92e-03 | 436 | 162 | 8 | EFO_0005110 | |
| Disease | Drugs used in diabetes use measurement | 2.93e-03 | 255 | 162 | 6 | EFO_0009924 | |
| Disease | YKL40 measurement | 3.00e-03 | 15 | 162 | 2 | EFO_0004869 | |
| Disease | cortical surface area measurement | ABI1 RAPH1 NBEAL1 MYO9B PKDCC ACVR2A MBD6 FMNL2 CELSR1 AFAP1 AUTS2 DMRTA1 TNKS POLD3 PRRC2A WNK2 | 3.08e-03 | 1345 | 162 | 16 | EFO_0010736 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.11e-03 | 109 | 162 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | platelet component distribution width | WIPF1 TENT4A MYO9B ARHGEF15 BCL6B NCOR2 MLXIPL SYT5 IRS2 PRRC2A TRIB1 | 3.13e-03 | 755 | 162 | 11 | EFO_0007984 |
| Disease | coffee consumption measurement | 3.39e-03 | 182 | 162 | 5 | EFO_0006781 | |
| Disease | Intellectual Disability | 3.39e-03 | 447 | 162 | 8 | C3714756 | |
| Disease | amygdala volume change measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0021490 | |
| Disease | autism spectrum disorder (is_implicated_in) | 3.42e-03 | 16 | 162 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | HOMA-B | 3.46e-03 | 55 | 162 | 3 | EFO_0004469 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.46e-03 | 55 | 162 | 3 | EFO_0022234 | |
| Disease | eosinophil count | CUX2 TENT4A ARHGEF18 ACVR2A KDM6B FOXA3 NACAD NCOR2 CELSR1 TBC1D4 SALL1 CSF2RB PELP1 PRKCSH TOX2 TRIB1 SYMPK | 3.46e-03 | 1488 | 162 | 17 | EFO_0004842 |
| Disease | triglycerides in very large VLDL measurement | 3.64e-03 | 56 | 162 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.64e-03 | 56 | 162 | 3 | EFO_0022333 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.64e-03 | 56 | 162 | 3 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.64e-03 | 56 | 162 | 3 | EFO_0022251 | |
| Disease | serum non-albumin protein measurement | 3.92e-03 | 361 | 162 | 7 | EFO_0004568 | |
| Disease | complex trait | 3.94e-03 | 271 | 162 | 6 | EFO_0010578 | |
| Disease | urate measurement | CUX2 FBRSL1 CHD3 ACVR2A DRAP1 MLXIPL ANKRD33 FMN1 LRP1 TMEM266 MYO18B MAP4K2 | 4.00e-03 | 895 | 162 | 12 | EFO_0004531 |
| Disease | low density lipoprotein particle size measurement | 4.02e-03 | 58 | 162 | 3 | EFO_0008593 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.10e-03 | 364 | 162 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | triglycerides in VLDL measurement | 4.22e-03 | 59 | 162 | 3 | EFO_0022326 | |
| Disease | body composition measurement | 4.34e-03 | 193 | 162 | 5 | EFO_0005106 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 4.42e-03 | 60 | 162 | 3 | EFO_0020690 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.42e-03 | 60 | 162 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.42e-03 | 60 | 162 | 3 | EFO_0022237 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.42e-03 | 60 | 162 | 3 | C4722327 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.52e-03 | 121 | 162 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | triglycerides in small HDL measurement | 4.85e-03 | 62 | 162 | 3 | EFO_0022158 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 4.85e-03 | 62 | 162 | 3 | EFO_0022339 | |
| Disease | cleft lip | 4.94e-03 | 284 | 162 | 6 | EFO_0003959 | |
| Disease | metabolic syndrome | 5.04e-03 | 200 | 162 | 5 | EFO_0000195 | |
| Disease | Deaf Mutism | 5.33e-03 | 20 | 162 | 2 | C4082305 | |
| Disease | chronic kidney disease (is_marker_for) | 5.33e-03 | 20 | 162 | 2 | DOID:784 (is_marker_for) | |
| Disease | Deafness, Acquired | 5.33e-03 | 20 | 162 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 5.33e-03 | 20 | 162 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 5.33e-03 | 20 | 162 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 5.33e-03 | 20 | 162 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 5.33e-03 | 20 | 162 | 2 | C0011052 | |
| Disease | basophil count | 5.38e-03 | 483 | 162 | 8 | EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPDSSPTDITPPPS | 121 | Q8WVB6 | |
| AAPPTLPPPPALPAS | 381 | Q9HCM7 | |
| APSAPPSPSAPEPPK | 376 | P55198 | |
| PGFPAPSPPPADSPS | 1306 | Q6ZSZ5 | |
| TPEPPPSPAAGAPLP | 316 | Q13202 | |
| SPEGPSEALPPPPPA | 1401 | O94910 | |
| PPDSGPPPLPTSSLP | 76 | Q8N556 | |
| SPPPPPPSSPSSSDA | 11 | Q504U0 | |
| VLVPTQDPGPPPPSP | 171 | P27037 | |
| ISVPPPSGAPPAPPL | 276 | Q8IZP0 | |
| PPPAAPPPSSSSVPE | 111 | Q8IXM2 | |
| PAGSPPPLTLPPTPS | 286 | Q99490 | |
| PSPSPSPSSLQPPPD | 776 | Q99490 | |
| EPAPRSPVPPPKPSG | 111 | O94989 | |
| PPASPPADGSPPLLP | 151 | Q6AI12 | |
| LPSAPTPDPPGPAPS | 76 | A0A0U1RR11 | |
| GTPSASPSPSPPLPP | 206 | Q9NYQ6 | |
| SPSPSPPLPPNLPEA | 211 | Q9NYQ6 | |
| SPVGPPTPPPAPTDP | 536 | Q9Y4F5 | |
| IPPPPAPGDSTTPPP | 596 | O60610 | |
| PPTAPATPAPGPEPL | 516 | O14529 | |
| PSNGLPPSPTPAAPP | 406 | P78524 | |
| PSGSCPAPLPAPSPP | 81 | Q8N5N4 | |
| SPSGPPASQPPPPRS | 1241 | Q9BXF3 | |
| APGSPSVPRPPPPAE | 36 | Q8TE57 | |
| TPSPLVPPGSSPLPP | 791 | Q07912 | |
| PSPPEEPSPLPSPTA | 261 | P49418 | |
| TPPPSQIPDPPFSSP | 721 | Q6ZS30 | |
| STLPLPPAPPGPSAP | 181 | Q14919 | |
| PPPPPPPASAAAPAS | 86 | Q96S59 | |
| ASTPPPGPPAPADPL | 236 | Q8NDT2 | |
| VPSPDFPPPPPESSL | 911 | Q70E73 | |
| SPPSDSDFPPPPPET | 1066 | Q70E73 | |
| LGTAPPPPLVPQSPP | 346 | Q7Z3H0 | |
| PIPPPPPLSSSFGVP | 241 | Q8N684 | |
| PPPPPLPSGLGSLSP | 876 | Q68DA7 | |
| SPAPAPTPTPAPSPA | 21 | Q92830 | |
| PPGSPEPPGLTQLSP | 16 | Q8IVL6 | |
| LSSPPGTLPPPPSGP | 421 | Q12851 | |
| NLLCPTPPPPPDTGP | 1986 | Q96PE2 | |
| TPPPPPDTGPEKLPS | 1991 | Q96PE2 | |
| GPPTPPPEDIPAPTE | 781 | Q9Y618 | |
| EATGAPTPPPAPPSP | 801 | Q9Y618 | |
| PPAPPPAPPLLSEAS | 36 | Q5KSL6 | |
| PPSDLLPPPSAPPSN | 606 | Q96DN6 | |
| PSCGPASPPATPPPE | 431 | Q8NCK7 | |
| GPPELPSESPPPELP | 761 | A5PL33 | |
| SPPSRPDTPESPGPP | 911 | Q02779 | |
| PLSPAPGPPTPAPES | 1856 | P78559 | |
| PGPPTPAPESHTPAP | 1861 | P78559 | |
| PPSPPPPPSEGFSIK | 156 | O75593 | |
| PLDPTPGPPASPNPF | 11 | Q643R3 | |
| PPAPTPAAPPPPSSA | 111 | O43365 | |
| RDPPPSPTEYPGPSP | 361 | Q96N19 | |
| EEAPPPLSPPQPASP | 336 | P14314 | |
| PSPTPPPDAPRPGTC | 4186 | Q07954 | |
| PPAAPPPLTEPGSSD | 396 | Q9P244 | |
| PQLGSIPPPPASAPP | 1301 | Q5JU85 | |
| LPPSATPPSPLHPSP | 536 | Q6VAB6 | |
| LPEAASSPPPAPPLP | 606 | B1AK53 | |
| PPPPLPGLATSPPFQ | 261 | O15054 | |
| TPHLSLPPGPSSPPP | 456 | O15054 | |
| PPEGDTDPSTPPAPP | 1376 | Q96Q04 | |
| EGRFPPTPPLFSPPP | 256 | Q9H165 | |
| GSPTTGLLLPPPPPP | 1071 | Q8ND23 | |
| PPTQESPPSPDPPSL | 1086 | Q8ND23 | |
| LGPPATPRCPSPEPP | 306 | O43593 | |
| PSPAPSPTVAPDPAP | 756 | O15534 | |
| VSTAPPLIPPPGFPP | 381 | Q6UN15 | |
| APPTALPPPPPLTSG | 461 | Q8WXX7 | |
| WTSDLPPPTPAPGPP | 1141 | Q7Z7M0 | |
| PGLPPAPAQPSSIPP | 1476 | Q9P1Y6 | |
| PDPLGPSPVPEASPP | 986 | Q9UQ05 | |
| PPAPPPSPAEDPTPD | 66 | A0A1B0GUC4 | |
| PGDSPSPEPSLPGPL | 351 | P48742 | |
| PTPPPDASPIPAPGD | 416 | Q96N21 | |
| PSPAPAPTVAEPSPP | 496 | Q86UU5 | |
| PTPAPVPPPEAPSPF | 646 | Q8IZL8 | |
| PTPPFPDPPSSLDPT | 71 | Q08378 | |
| TPPPSALPLGAPPPD | 216 | Q9BQQ3 | |
| PALPAASPPPPGPTA | 46 | Q5XG87 | |
| ASPPPPGPTAPAALP | 51 | Q5XG87 | |
| TIPPSAPPIAPPGTP | 1341 | O60244 | |
| PLPPSAPPSAPPSAD | 311 | E5RHQ5 | |
| PPPVPPPPSSEALNG | 46 | P49023 | |
| SSSLQPPPPPPAPGE | 1026 | Q9Y4H2 | |
| STSGPPTPPLLPPFP | 1801 | Q96QU1 | |
| GTPPPLPARSSPPSP | 241 | Q8NC74 | |
| APPPSLPSPSRLPGP | 141 | Q6NT52 | |
| LPTEQPPSPQPGPPA | 561 | P32927 | |
| PVPSPPPMSSPHPGS | 346 | Q9Y2F5 | |
| EAEPPTPPTAPPPGS | 146 | Q8N143 | |
| LPSAPTPDPPGPAPS | 76 | P0DPI3 | |
| PAAPLTPGPQSPPTP | 166 | O75398 | |
| PAPGPTPAEPPTAPS | 1986 | Q8TD84 | |
| PEEAPGPLPPPPTPS | 286 | Q7L513 | |
| ATPIAPSGPPALPPP | 231 | Q12873 | |
| TPPSGTPSPGPPPAL | 41 | Q96A19 | |
| AAPPPPSPALPVPSG | 26 | Q5VZB9 | |
| DPPSPPSQPPTPATA | 321 | Q6P1N0 | |
| AAVSTTPPGSPPPPP | 1251 | Q9BTC0 | |
| PPPSPAPSDSPASPD | 1591 | Q9BZC7 | |
| PLAPPLPSAPPLPGT | 586 | Q96PY5 | |
| PSTPVPPSPAPAPGL | 101 | Q96EZ8 | |
| TPPEPRPSPEGDPSP | 21 | Q3KQU3 | |
| APASPAPSPAPSPTP | 541 | Q3KQU3 | |
| SPLTPCPPGVPSPSP | 146 | Q6ZN01 | |
| FPSLPPPPGSASLPP | 441 | Q96QS3 | |
| PPLPGLPSPQEAPPS | 546 | O95466 | |
| PAPPTPPGSLRAPLP | 276 | O43638 | |
| LFTPGSPTPSPPPLP | 276 | Q5T7N3 | |
| PPPRAPAPAPPGTVT | 211 | Q12929 | |
| PAPDPGSPRTPPPTS | 131 | Q96LL9 | |
| VPCPPPSPGPSAVPS | 371 | O95817 | |
| GSPTPAPPVPLPTAP | 191 | P0C264 | |
| PPETFSPSPPPDNPD | 81 | Q9NSC2 | |
| PPASPPGAPASPRAP | 776 | Q9UL51 | |
| PVGPSPASPSPEPPV | 821 | Q5VV67 | |
| PPEPPTGLPARTPAP | 86 | Q9BTV7 | |
| AAAEPPPSPPPPSLL | 71 | Q9Y661 | |
| PIPGPPPRSVPPTDF | 296 | Q659C4 | |
| PTPGPPSPDTPPDSS | 6 | O00445 | |
| PLSPLSPEPPGAPVP | 106 | Q9H987 | |
| SPEDGASPSSPPLPP | 6 | Q9NRF2 | |
| VETPPDPSPPSAPAP | 6 | O94763 | |
| EPPRPGQSPEPSPAP | 31 | Q504Y2 | |
| ACSPPPPKGFTPPPL | 221 | B4DYI2 | |
| PPSPEPPPSPGSADP | 481 | A6NKL6 | |
| PPPSPGSADPDSSPL | 486 | A6NKL6 | |
| PADTSVAFPPPPPPS | 131 | H3BV60 | |
| PRFSSLSPPPPPPGL | 161 | P78426 | |
| LPPPPLAPSEGRPTP | 6 | Q8N3V7 | |
| PASPLPSGPLAPPAP | 56 | P55318 | |
| PSPPASPPLSPLATP | 856 | Q9H6K5 | |
| LALAPGPPPPPSRSP | 1096 | Q9H6K5 | |
| SRPPETEPGPPAPKP | 396 | P48634 | |
| PPAAPSTPAPPPAVP | 511 | P48634 | |
| PPAPPPASAPTPETE | 531 | P48634 | |
| PPSQCEPTSLPPGPP | 6 | Q969X2 | |
| TDLPPPLPPGPPSIF | 56 | P51888 | |
| PPPPAASSTSGPQPP | 66 | Q15714 | |
| ELLTPPPGTTAPPPP | 121 | Q6UXD5 | |
| AESPSPPPPPSPPLE | 346 | Q15054 | |
| LACSPPPPKGFTPPP | 226 | P0DKV0 | |
| PFPTVPPAPGVSPLP | 436 | Q9NP71 | |
| TPPRPPPGPATLAPS | 576 | Q9NP71 | |
| DPPTPPSSTPSFKPP | 496 | Q9NZP6 | |
| SPLPDPGTPLPPDPT | 1186 | Q8TAQ2 | |
| PGTPLPPDPTAPSPG | 1191 | Q8TAQ2 | |
| RGEPPTPPSPAPAPA | 1286 | Q96RK0 | |
| APQPSPPPPGPSTAA | 1591 | Q96RK0 | |
| TDPPAPRTPPEPPGS | 1181 | Q14028 | |
| EPPGSPPSSPPPASL | 1191 | Q14028 | |
| PTPRPCAGPAPPPAS | 126 | Q9H7T3 | |
| PTPPPAVTSAPPGAP | 151 | P23246 | |
| AVTSAPPGAPPPTPP | 156 | P23246 | |
| PPSPPPPPPSNASSE | 2116 | A4UGR9 | |
| LAPSFPPEPPPPGLT | 141 | Q6B0B8 | |
| ALIPSPPPPPLGTSP | 396 | Q96MX3 | |
| PLPAPSQTPPGPPAA | 186 | P0CJ78 | |
| SPPGSPCSPQPPPAA | 61 | Q96RU8 | |
| PPGPPAQPAATPTSP | 321 | Q15772 | |
| PDSGLPPSPSPSPPF | 26 | Q6ZTI6 | |
| PSPPPPGSEAAPSPS | 686 | Q96GP6 | |
| PDPPTEPSSPPGAPS | 546 | Q96MS0 | |
| PPPPLSPGLAPGTTP | 31 | O95271 | |
| PSTSGISALPPPPPP | 506 | Q7Z7A4 | |
| PPPPAAPLPPASTEA | 521 | Q7Z7A4 | |
| DRPSAGAPPPPPPST | 421 | O43516 | |
| PPEPGPTPPAAPASP | 521 | O14492 | |
| RLPPPGPPQAPPSDT | 231 | Q9BUL5 | |
| LPPPPPLFPTTASPG | 726 | Q9UFB7 | |
| PGDSPPGTPPASPPS | 606 | O60343 | |
| GSSLQSFPLPPPPPP | 336 | O14512 | |
| SPSPSPSARPGPPPS | 1171 | Q92797 | |
| LPPLSSATPPPGIPP | 621 | P49750 | |
| PPPSSPPPLFSVIPG | 21 | Q8IUG5 | |
| PPPSPGTPSATPASP | 261 | Q4KMQ1 | |
| PGLSASPPPPPSFPL | 366 | Q96NM4 | |
| SPPPPPSFPLSPTLH | 371 | Q96NM4 | |
| GVTAEKAPPPPPPPT | 456 | O60346 | |
| PLPPPAPEPSPHSGT | 1511 | Q9Y3S1 | |
| PSSPLQPLPPSPSPG | 226 | Q6ZRP0 | |
| EEPSSEPGPSPPPLP | 416 | Q2M3C6 | |
| LAPPAPPSPASPDPE | 11 | Q5T230 | |
| PPSPASPDPEPRTPG | 16 | Q5T230 | |
| PPPPPLLSPPSFSSG | 51 | Q6UXQ8 | |
| EASPPPKSPAEPPAP | 501 | A6NMK8 | |
| PPPEESPTSPPPEAS | 451 | O14686 | |
| PPPEESPLSPPPESS | 496 | O14686 | |
| SPTSPPPEDSPASPP | 696 | O14686 | |
| LSAPPPEEPSPPPSP | 4906 | O14686 | |
| PEEPSPPPSPLAPSP | 4911 | O14686 | |
| PPPAPPAPAPASSAP | 776 | Q9P206 | |
| PPPDPDSFFTPPSTP | 166 | O15069 | |
| PKGAPTPPAATPPSP | 936 | E9PAV3 | |
| PPPKGAPTTPAATPP | 1166 | E9PAV3 | |
| PKGAPTPPAATPPSP | 1306 | E9PAV3 | |
| PPAPALPCPGAPTPS | 2021 | Q13459 | |
| PPGPTEPTPPPFTFS | 786 | Q86TC9 |